Stiff Back Every Morning? What the HLA-B27 Test Really Tells You About Ankylosing Spondylitis

Five signs your morning stiffness points at inflammation

You don't need to memorise criteria. Just run through these five questions honestly.

1. Are you under 45, and has this been going on for more than three months? Ankylosing spondylitis usually announces itself between 20 and 30. Late teens, early adulthood. It creeps in slowly, not after one bad lift.

2. Does the stiffness last more than half an hour in the morning? Set a rough mental timer. If you're still moving like a rusted hinge at 8:30 after waking at 7, that counts. Fifteen minutes of morning grogginess is normal at any age. Forty-five minutes is a pattern.

3. Does moving help and resting make it worse? This is the big one. A walk around the building loosens you up. A long car ride or a lazy Sunday on the couch stiffens you right back up. Mechanical pain is the mirror image: rest soothes, movement aggravates.

4. Does pain wake you in the second half of the night? Not 11 pm, when you first fell asleep. More like 3 or 4 am. You get up, pace the room, maybe sit in a hot shower, and it eases. Then you wonder why a back problem responds to being awake.

5. Does the pain alternate between buttocks? The disease starts in the sacroiliac joints, the joints where your spine meets your pelvis, so early pain often sits deep in one buttock, then switches sides over weeks or months. A slipped disc picks a side and stays there.

One yes is nothing. Three or four yeses, and a rheumatologist would want to see you. Notice that none of these questions mention blood tests. The story comes first; the tests come later. That's how diagnosis actually works.

The sacroiliac joints: where this disease starts

Put your hands on your lower back, then slide them down to where the spine meets the pelvis, just above the buttocks. Somewhere under your thumbs are the sacroiliac joints. Two of them, left and right. They're the shock absorbers between your upper body and your legs, and they barely move.

In ankylosing spondylitis, these joints are where the inflammation begins. The medical word is sacroiliitis, and it's the hallmark of the disease. Early on, there's nothing to see on an ordinary X-ray. The inflammation is there, in the bone marrow, but the bones themselves still look normal. This is the main reason diagnosis takes so long: the disease is real and active for years before the bones show it.

Over time, in people whose disease progresses, the repeated cycles of inflammation and healing can cause new bone to form. The spine can gradually stiffen, vertebrae fusing together, which is where the old name for the disease came from: "ankylosing" means stiffening or fusing. This doesn't happen to everyone, and modern treatment aims squarely at preventing it, but it explains why doctors take early, persistent inflammatory back pain so seriously. The goal is to act while the damage is still preventable.

There's a Mumbai pattern we've noticed over the years. A young man in his late 20s or early 30s has had "back pain" for years. He's been told it's a disc problem, sometimes given an MRI of the lumbar spine that shows some mild disc bulge, which almost every adult has. Nobody images the sacroiliac joints. Nobody asks whether mornings are the worst part of his day. The real question was never asked, so the real test was never ordered.

What the HLA-B27 blood test actually measures

HLA-B27 is a protein that sits on the surface of your white blood cells. It belongs to a family of proteins whose job is to help the immune system tell "self" from "foreign." The gene that codes for it comes in many variants; researchers have catalogued more than 200.

The test looks for this marker in your blood. There are two legitimate ways labs do it. Some use flow cytometry, which detects the actual protein sitting on the surface of white blood cells. Others use PCR, which detects the gene itself. Our HLA-B27 test uses the PCR method and reports the result as qualitative: positive or negative. There's no number to interpret, no range to fall inside. The report page has essentially one line on it.

A few practical facts worth knowing:

• It's a standard venous blood draw from a vein in your arm. The needle prick stings for a few seconds, then the phlebotomist presses a cotton ball to the spot and tapes it down. That's the whole event.
• No fasting needed. No special preparation. You can eat breakfast, take your usual medicines, and show up whenever.
• Once positive, always positive. This is a genetic marker, not an inflammation level, so treatment doesn't change it and there's no reason to repeat it later.
• One honest technical caveat, from the reference labs that run this test: a couple of rare gene variants (B27:06 and B27:09) aren't linked to the disease, and extremely rare variants may not be picked up. This affects a tiny fraction of people, but it's worth knowing the test has edges like any test.

Before the blood draw

Do: tell the person drawing your blood about any blood thinners you take, so they can press the cotton ball a little longer. Eat normally and drink water; a hydrated vein is an easier vein, and our phlebotomists do these draws at home across Malad, Kandivali, Borivali and Goregaon every day.

Don't: skip the test because you're worried about fasting rules that don't exist for this one, and don't stop any regular medicine beforehand. There is nothing to prepare for, which is honestly the easiest kind of test.

A positive report: what it means, and what it doesn't

So the report says positive. Here's how to read it.

What it means: you carry the marker that shows up in roughly 80 to 90 percent of people with ankylosing spondylitis. In the right symptom context, that is a meaningful clue. It's also associated with a small family of related conditions: reactive arthritis (the kind that can follow certain infections), psoriatic arthritis with spinal involvement, arthritis linked to inflammatory bowel disease, and acute anterior uveitis, which is inflammation inside the eye. Doctors call this whole family the spondyloarthritides.

What it doesn't mean: it doesn't mean you have, or will get, any of those conditions. Only about 2 to 8 percent of HLA-B27-positive people develop ankylosing spondylitis. Put differently, if you lined up a hundred positive people, roughly 92 to 98 of them would never develop the disease. Your genes loaded a small extra risk; they didn't write a prescription.

The question we hear most at the counter is some version of: "My report says positive. Does my wife need this test? Do my children need it?" The honest answer: the gene can be passed to children, and having a family history does raise the risk substantially compared to a positive person with no family history. But inheriting the gene is not inheriting the disease. Most carriers, including most children of carriers, stay perfectly healthy. Testing family members who have no symptoms doesn't change anything and mostly just manufactures worry. The exception is if someone in the family develops the classic pattern: persistent morning stiffness, pain that improves with movement. Then the test becomes useful again, because now there's a question to answer.

Population numbers vary more than most articles admit, so here's the honest version. In Western studies, about 6 to 8 percent of the general population carries HLA-B27. Indian studies report a wider spread, roughly 1.4 to 8 percent depending on the region and the method, and one large North Indian study of over 7,000 people found about 4 percent. Among Indian patients with ankylosing spondylitis, the reported positivity swings wildly from study to study, anywhere from about a quarter to over 90 percent, because the studies are small, from different regions, and use different methods. The Western 80 to 90 percent figure doesn't hold uniformly in Indian data. That's not a contradiction; it's what happens when you measure a real, messy population.

A negative report: the search doesn't end there

Roughly one in ten people with ankylosing spondylitis are HLA-B27 negative. They have the disease, the inflammation, the morning stiffness, the whole picture, and this particular marker simply isn't there.

This is the group that gets misdiagnosed the longest. A negative result gives everyone, patient and doctor both, a false sense of reassurance. "The test was negative, so it can't be that." But the test was never a yes-or-no for the disease. It was always one clue among several, and clues can be absent while the case is still real.

If your mornings still follow the inflammatory pattern, stiffness over 30 minutes, better with movement, worse with rest, night pain, alternating buttock pain, then a negative HLA-B27 doesn't close the file. It just means the diagnosis will rest more heavily on the other pillars: the clinical story, the inflammation markers, and the imaging. A good rheumatologist knows this. If your doctor waved away months of classic symptoms because of one negative blood test, that's worth a second opinion, not a shrug.

There's a related marker worth a passing mention. Some people with chronic joint pain get an ANA blood test instead, or as well, and then try to read the two together. They're different markers for different families of disease. ANA points toward lupus and related conditions; HLA-B27 points toward the spondyloarthritis family. One doesn't cancel the other. If your reports contain both, bring both to the rheumatologist and let them sort the overlap.

The rest of the workup: CRP, ESR, X-ray, and the MRI that sees years earlier

HLA-B27 is one piece. Here's what a rheumatologist typically orders alongside it, and why each piece matters.

CRP and ESR. These are general inflammation markers, measured from the same kind of blood draw. CRP (C-reactive protein) rises and falls relatively quickly with inflammation; the ESR test (erythrocyte sedimentation rate) is the older, slower-moving cousin. Here's the catch that surprises people: about half of people with axial spondyloarthritis have completely normal CRP and ESR. Normal markers don't rule the disease out, just like a negative HLA-B27 doesn't. They're useful when they're high, and uninformative when they're not.

RA factor and anti-CCP. These point toward rheumatoid arthritis, a different disease. In ankylosing spondylitis they're typically negative, and that's the point: a negative RA factor and negative anti-CCP test help the doctor say "this looks like the spondyloarthritis family, not rheumatoid arthritis." Tests that come back negative can be just as informative as the ones that come back positive.

X-ray of the sacroiliac joints. This is usually the first imaging step. It looks for the structural changes of sacroiliitis: erosion, sclerosis, and eventually fusion. The problem is timing. These changes can take years to appear, in some cases up to a decade after symptoms start. An early X-ray that looks normal proves nothing except that it's early.

MRI of the sacroiliac joints. This is the tool that changed the game. An MRI can see active inflammation, the bone-marrow edema that an X-ray can't, years before structural damage shows up. When a young adult has the classic symptom pattern and the X-ray is clean, the MRI of the SI joints is often what finally settles it. If your doctor has only ever imaged your lumbar spine, ask specifically about the sacroiliac joints. They're different joints, and the lumbar MRI doesn't cover them properly.

The formal criteria rheumatologists use, the ASAS criteria for axial spondyloarthritis, reflect exactly this logic. In someone with chronic back pain starting before 45, the diagnosis can rest on sacroiliitis on imaging plus one disease feature, or on HLA-B27 positivity plus two features, where the features include inflammatory back pain, arthritis, heel pain (enthesitis), uveitis, psoriasis, inflammatory bowel disease, a good response to anti-inflammatory medicines, a family history, or raised CRP. Notice how the test is one ingredient in a recipe, never the whole dish.

Why diagnosis takes years, and what the Indian numbers say

The average delay between first symptoms and diagnosis is measured in years, not months. In the UK, patient guidance quotes four to nine years. In India, a study of 70 patients at a rheumatology clinic found a mean delay of 6.9 years, and the reasons are painfully familiar: about 35 percent had been told it was non-specific back pain, 26 percent degenerative disc disease, 20 percent rheumatoid arthritis, and 17 percent spinal tuberculosis. Three-quarters of the wrong diagnoses came from orthopaedic surgeons, half from general physicians. Nobody's villain here; inflammatory back pain genuinely mimics mechanical problems, and most back pain a general doctor sees is mechanical.

Another Indian study of 70 patients put the numbers in human terms: symptoms started at an average age of 23.6, diagnosis came at 32.5. Nine years. Men outnumbered women five to one in that cohort, though doctors increasingly recognise the disease is underdiagnosed in women rather than absent in them. The most common extra joint symptom at the start was inflammatory low back pain, in 87 percent. An estimated 16.5 lakh Indians live with the condition, going by recent Indian medical reporting.

There's a reason the delay matters beyond frustration. The treatments we have now work best early, before structural damage accumulates. Every year of "it's just a disc problem" is a year the inflammation works unopposed. If you're the person living those years, you don't need the statistics. You need one doctor who asks the right five questions from the section above.

A red, painful eye with back stiffness: don't wait

Of all the complications, one deserves its own section because it's urgent.

About a quarter to a third of people with ankylosing spondylitis develop acute anterior uveitis at some point: sudden inflammation inside the eye. It announces itself clearly. One eye turns red. It hurts, genuinely hurts, not just feels tired. Light becomes uncomfortable. Vision goes blurry. This is not conjunctivitis and it's not eye strain from a screen.

If this happens to you, especially if you already carry the back-pain story, see an eye specialist immediately. Uveitis needs prompt treatment to protect vision, and it responds well when caught early. Mention the back symptoms and the HLA-B27 status to the eye doctor; the connection is well known to them, but saying it out loud speeds everything up.

Two other red flags, rarer but worth one line each. If your spine has significantly fused and stiffened over the years, even a minor fall can fracture it, so new severe back pain after any trauma needs emergency evaluation. And any new numbness, weakness, or bladder or bowel changes alongside back pain is always an emergency, whatever the underlying diagnosis.

Nine questions patients ask us at the counter

My HLA-B27 came back positive. Does that mean I have ankylosing spondylitis? No. It's a risk marker, not a diagnosis. Only about 2 to 8 percent of carriers develop the disease. What matters now is whether your symptoms fit the pattern, and what imaging shows.

Mine says negative, but my back still hurts every morning. Can I still have it? Yes. Around one in ten people with ankylosing spondylitis are HLA-B27 negative. The diagnosis is built from symptoms, markers, and imaging together.

What does inflammatory back pain actually feel like? Morning stiffness lasting over 30 minutes, pain that eases with movement and worsens with rest, aching that wakes you in the second half of the night, sometimes alternating between buttocks. If that paragraph felt familiar, talk to a rheumatologist.

Is this inherited? Will my children get it? The gene can be passed on, but inheriting the gene isn't inheriting the disease. Family history raises the risk, yet most carriers, including children of carriers, never develop it. Don't test symptom-free family members.

Do I need to repeat the HLA-B27 test later? Does treatment change it? No to both. It's a genetic marker. Treatment calms inflammation; it doesn't rewrite genes.

Which tests will the rheumatologist actually order? Usually CRP and ESR, an X-ray of the sacroiliac joints, and often an MRI of those joints, which shows inflammation years before X-rays do. RA factor and anti-CCP may be added to rule out rheumatoid arthritis.

Why did it take so long for anyone to figure this out? Because early X-rays look normal and the pain mimics ordinary back trouble. The average delay is 5 to 10 years worldwide and about 7 years in Indian studies. You're not imagining it, and you're not alone in the wait.

My eye suddenly turned red and painful. Should I wait and see? No. See an eye specialist right away. Acute anterior uveitis needs urgent treatment to protect your sight.

Can this be cured if it's caught early? There's no cure, but early treatment genuinely changes the trajectory: symptoms controlled, mobility preserved, and a real reduction in the risk of the spine fusing. "No cure" and "no hope" are very different things.

Living with it: movement, medicine, and the Mumbai practical bits

Here's the part nobody expects: for this disease, exercise isn't a lifestyle suggestion. It's treatment. International guidelines put physical therapy and regular exercise at the very centre, alongside medicines. Daily stretching and range-of-motion work for the spine, hips, and shoulders. Posture training, because a stiffening spine drifts forward if you let it. Swimming and walking come up again and again as the friendliest options. A hot shower in the morning loosens things before the day starts. One delightfully specific tip from rheumatology patient guides: sleep with one thin pillow rather than a stack, to keep the neck from fixing into a forward bend.

Medicines follow a ladder. Anti-inflammatory painkillers (NSAIDs) are usually first, taken regularly rather than only on bad days. If those plus exercise aren't enough, rheumatologists move to biologic medicines: TNF blockers or IL-17 blockers, given by injection. Newer JAK inhibitor tablets are another option in some situations. Steroid injections go into specific inflamed joints only, not as a long-term strategy. The older immune-suppressing tablets used in rheumatoid arthritis help the peripheral joints in this disease but not the spinal disease itself. Before starting biologics, doctors routinely screen for tuberculosis and hepatitis, because these medicines affect the immune system. That's standard practice, not a cause for alarm.

Two habits matter more than any supplement marketed to you. Don't smoke; it worsens the disease and blunts treatment. And keep moving on the good days, not just the bad ones. No diet cures this, whatever the internet says. Staying active, keeping an upright posture, and not smoking are the habits with actual evidence behind them.

Now the practical Mumbai part. If a doctor has asked you to get HLA-B27 done, along with CRP, ESR, or the arthritis markers, you don't need to plan a morning around a lab visit. Our phlebotomists do home collection across Malad, Kandivali, Borivali and Goregaon, the draw takes a few minutes at your doorstep, and reports are typically ready in about 24 hours. The lab itself runs 24x7, so an early-morning-before-office draw is genuinely possible. Bookings are on 84250 40353. If your doctor mentioned a broader workup, the Arthritis Panel and the Autoimmune & Arthritis Screening Panel bundle the relevant markers together, and you can browse everything else on the tests page.

Six things to carry away from this article. HLA-B27 is a genetic marker, not a diagnosis. Morning stiffness over 30 minutes that eases with movement is the classic pattern worth acting on. A positive result raises suspicion; a negative one doesn't rule the disease out. Diagnosis needs the full picture, and MRI sees what X-rays miss for years. Most HLA-B27-positive people never develop ankylosing spondylitis, so a positive report is information, not a sentence. And a red, painful eye alongside back symptoms needs an eye specialist fast. If your mornings have been trying to tell you something for months, listen to them, and get the right doctor to listen too.

References

• ARUP Consult: Ankylosing Spondylitis, HLA-B27 Genotyping (test fact sheet and sample report)
• MedlinePlus Medical Encyclopedia: HLA-B27 antigen
• Mayo Clinic: Ankylosing spondylitis, symptoms, causes, treatment
• NHS (nhs.uk): Ankylosing spondylitis, diagnosis and treatment (reviewed January 2023)
• NHS Lanarkshire and City & Hackney CCG: primary-care guides on inflammatory back pain and axial spondyloarthritis
• Royal Free London NHS Foundation Trust: axial spondyloarthritis patient information
• Assessment of SpondyloArthritis international Society (ASAS): classification criteria for axial spondyloarthritis
• American College of Rheumatology / SAA / SPARTAN treatment recommendations (2019 update)
• Aggarwal R, Malaviya AN. Diagnosis delay in ankylosing spondylitis, Clinical Rheumatology 2009 (PMID 19052836)
• Indian Journal of Medical Sciences 2024: Prevalence of HLA-B*27 in the North Indian population